Sarfraz Memon

Also affiliated with National Cancer Institute

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention”.

High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention

Blood Advances(2024)10.1182/bloodadvances.2023010973

N/A

0.451DataRank · unranked

11 citations

Lauren M. Curtis, Rachel B. Salit, Brian C. Shaffer, Filip Pirsl, Alen Ostojić +14 more